Barclays PLC Clovis Oncology, Inc. Put Options Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2021

May 13, 2021
SELL
$4.81 - $10.34 $207,791 - $446,688
-43,200 Reduced 83.24%
8,700 $61,000
Q4 2020

Feb 11, 2021
SELL
$4.13 - $6.41 $65,254 - $101,278
-15,800 Reduced 23.34%
51,900 $249,000
Q3 2020

Nov 12, 2020
SELL
$4.82 - $7.72 $22,654 - $36,284
-4,700 Reduced 6.49%
67,700 $394,000
Q2 2020

Aug 12, 2020
SELL
$5.69 - $9.69 $157,044 - $267,444
-27,600 Reduced 27.6%
72,400 $488,000
Q1 2020

May 13, 2020
SELL
$3.77 - $11.0 $201,318 - $587,400
-53,400 Reduced 34.81%
100,000 $636,000
Q4 2019

Feb 10, 2020
BUY
$3.0 - $16.43 $317,400 - $1.74 Million
105,800 Added 222.27%
153,400 $1.6 Million
Q3 2019

Nov 14, 2019
BUY
$3.93 - $15.35 $104,538 - $408,310
26,600 Added 126.67%
47,600 $187,000
Q2 2019

Aug 14, 2019
SELL
$12.81 - $25.67 $313,845 - $628,915
-24,500 Reduced 53.85%
21,000 $312,000
Q1 2019

May 15, 2019
BUY
$17.66 - $30.28 $164,238 - $281,604
9,300 Added 25.69%
45,500 $1.13 Million
Q4 2018

Feb 14, 2019
SELL
$11.63 - $32.67 $36,053 - $101,277
-3,100 Reduced 7.89%
36,200 $650,000
Q3 2018

Nov 14, 2018
SELL
$29.37 - $49.48 $1.1 Million - $1.85 Million
-37,300 Reduced 48.69%
39,300 $1.15 Million
Q2 2018

Aug 14, 2018
BUY
$42.06 - $62.4 $954,762 - $1.42 Million
22,700 Added 42.12%
76,600 $3.48 Million
Q1 2018

May 15, 2018
SELL
$50.12 - $67.72 $2.43 Million - $3.28 Million
-48,400 Reduced 47.31%
53,900 $2.85 Million
Q4 2017

Feb 14, 2018
SELL
$57.69 - $84.58 $1.49 Million - $2.19 Million
-25,900 Reduced 20.2%
102,300 $6.96 Million
Q3 2017

Nov 14, 2017
BUY
$67.17 - $84.81 $8.61 Million - $10.9 Million
128,200
128,200 $10.6 Million

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0
View Full List

About Clovis Oncology, Inc.

CLVS Quotes by TradingView
  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email